Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Allogeneic stem cell transplant results in t-cell prolymphocytic leukemia (T-PLL): A collaborative multi-center study cohort

Blood (2025) 146 (Supplement 1): 1054.

https://doi.org/10.1182/blood-2025-1054

Published: 2025

Journal Articles

PRMT5 is a therapeutic vulnerability in cutaneous T-cell lymphoma

Nicole Peterman, Pushpa Lata, Christoph Weigel, Sydney Leon, Ian Hout, Wing Chan, Ronny Schmidt, Ha Tran, Youssef Youssef, Peggy Scherle, Neha Bhagwat, John Reneau, Catherine Chung, Jonathan Brammer, Ryan Wilcox, Lapo Alinari, Robert Baiocchi, Walter Hanel

Blood (2025) 146 (Supplement 1): 1529.

https://doi.org/10.1182/blood-2025-1529

Published: 2025

Journal Articles

Final results of a phase 1 trial with soquelitinib (SQL), a selective interleukin-2-inducible T cell kinase (ITK) inhibitor for treatment of relapsed/refractory (R/R) T cell lymphomas (TCL)

Richard Miller, Ryan Wilcox, John Reneau, Costas Yannakou, Won Seog Kim, Tatyana Feldman, Youn-H Kim, Michael Khodadoust, Dejan Radeski, Robin Gasiorowski, Dok Hyun Yoon, Yuqin Song, Andrew Hotson, Suresh Mahabhashyam

Blood (2025) 146 (Supplement 1): 778.

https://doi.org/10.1182/blood-2025-778

Published: 2025

Journal Articles

GATA-3 identifies a distinct subset of T-cell prolymphocytic leukemia (T-PLL) and is associated with CCR4 expression

Marc Gutierrez, Carlos Murga Zamalloa, Kedar Inamdar, Michael Stone, Vida Ehyaee, Philip Boonstra, Ryan Wilcox

Blood (2025) 146 (Supplement 1): 1877.

https://doi.org/10.1182/blood-2025-1877

Published: 2025

Journal Articles

Evaluation of Multiple Myeloma Clinical Decision Support Tool Value When Populated with Community Health System Data

Steven E. Labkoff, MD, Kathy E. Giusti, MBA, Paul A. Giusti, MBA, Ryan Wilcox, MD, Derrick Haslem, MD, Daanish Hoda, MD, Kerry Rowe, PhD, Gail Fulde, Jesse Gygi, MHA, MPH, Brad Bott, MBA, Ben Smith

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-141458

Published: 2020

Journal Articles

Safety of Mogamulizumab in Mycosis Fungoides and Sézary Syndrome: Final Results from the Phase 3 Mavoric Study

Youn H. Kim, MD, Martine Bagot, MD PhD, Pier Luigi Zinzani, MD PhD, Madeleine Duvic, MD, Stephen Morris, MBBS, MRCP, FRCR, Ellen Kim, MD, Amy Musiek, MD, Pablo L. Ortiz-Romero, MD PhD, Craig Elmets, MD, Herbert A. Eradat, MDMS, Nina Magnolo, MD, Julia Scarisbrick, MD, Stéphane Dalle, MD PhD, David C. Fisher, MD PhD, Michi Shinohara, MD, Brian Poligone, MD PhD, Barbara Pro, MD, Pietro Quaglino, MD, Nishitha Reddy, MD MSCI, Brigitte Dreno, MD, Larisa J Geskin, MD, Ahmad S Halwani, MD, Amit Khot, MD, Marie Beylot-Barry, MD PhD, Neil Korman, MD, Frederick Lansigan, MD, Steven M. Horwitz, MD, Zanetta S. Lamar, MD, Alison J. Moskowitz, MD, Jillian Wells, MD, Oleg E. Akilov, MD PhD, Dolores Caballero, MD PhD, Richard Cowan, MBBS, MD MRCP, FRCR, Reinhard Dummer, MD, Mary Jo Lechowicz, MD, Francine M. Foss, MD, Lars Iversen, MD, Tomomitsu Miyagaki, MD PhD, Ryan Wilcox, MD, Pierluigi Porcu, MD, Maarten Vermeer, MD PhD, Sunil Abhyankar, MD, Yukihiko Kato, MD PhD, Theresa Pacheco, MD, Shigetoshi Sano, MD PhD, Basem M. William, MRCP,MD, Timothy S. Fenske, MD, Noriko Fukuhara, MD PhD, Koji Habe, MD PhD, Toshihisa Hamada, MD PhD, Eiji Kiyohara, MD PhD, Bryone J. Kuss, MBBS, PhD FRACP, FRCPA, Adam Lerner, MD, Lawrence Mark, MD PhD, Javier Munoz, MD, Hiroyuki Okamoto, MD PhD, Christiane Querfeld, MD PhD, Jiro Uehara, MD, Hisashi Uhara, MD PhD, Kentaro Yonekura, MD PhD, Auris Huen, MD, Kensei Tobinai, MD PhD, Yoshiki Tokura, MD PhD, Erin Boh, MD PhD, Jan Nicolay, MD, Hidefumi Wada, MD, Mollie Leoni, MD, Takahiro Ito, MSc, Fiona Herr, PhD, Lubomir Sokol, MD PhD

Blood (2019) 134 (Supplement_1): 5300.

https://doi.org/10.1182/blood-2019-122778

Published: 2019

Journal Articles

Molecular Subgroups of Peripheral T-Cell Lymphoma Evolve By Distinct Genetic Pathways

Blood (2016) 128 (22): 4096.

https://doi.org/10.1182/blood.V128.22.4096.4096

Published: 2016

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Allogeneic stem cell transplant results in t-cell prolymphocytic leukemia (T-PLL): A collaborative multi-center study cohort

PRMT5 is a therapeutic vulnerability in cutaneous T-cell lymphoma

Final results of a phase 1 trial with soquelitinib (SQL), a selective interleukin-2-inducible T cell kinase (ITK) inhibitor for treatment of relapsed/refractory (R/R) T cell lymphomas (TCL)

GATA-3 identifies a distinct subset of T-cell prolymphocytic leukemia (T-PLL) and is associated with CCR4 expression

Evaluation of Multiple Myeloma Clinical Decision Support Tool Value When Populated with Community Health System Data

Safety of Mogamulizumab in Mycosis Fungoides and Sézary Syndrome: Final Results from the Phase 3 Mavoric Study

Molecular Subgroups of Peripheral T-Cell Lymphoma Evolve By Distinct Genetic Pathways

Email alerts

ASH Publications

American Society of Hematology

Update search

Allogeneic stem cell transplant results in t-cell prolymphocytic leukemia (T-PLL): A collaborative multi-center study cohort

PRMT5 is a therapeutic vulnerability in cutaneous T-cell lymphoma

Final results of a phase 1 trial with soquelitinib (SQL), a selective interleukin-2-inducible T cell kinase (ITK) inhibitor for treatment of relapsed/refractory (R/R) T cell lymphomas (TCL)

GATA-3 identifies a distinct subset of T-cell prolymphocytic leukemia (T-PLL) and is associated with CCR4 expression

Evaluation of Multiple Myeloma Clinical Decision Support Tool Value When Populated with Community Health System Data

Safety of Mogamulizumab in Mycosis Fungoides and Sézary Syndrome: Final Results from the Phase 3 Mavoric Study

Molecular Subgroups of Peripheral T-Cell Lymphoma Evolve By Distinct Genetic Pathways

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only